共 50 条
Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses
被引:0
|作者:
Yachida, Junko
[1
,2
]
Fujihara, Kazuya
[1
]
Yamada, Mayuko Harada
[1
]
Kobayashi, Ayako
[1
,2
]
Khin, Lay Mon
[1
]
Takizawa, Hiroki
[1
]
Yamamoto, Masahiko
[1
]
Kitazawa, Masaru
[1
]
Matsubayashi, Yasuhiro
[1
]
Yamada, Takaho
[1
]
Kodama, Satoru
[1
]
Sone, Hirohito
[1
]
机构:
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan
[2] Niigata Coll Nursing, Joetsu, Japan
基金:
日本学术振兴会;
关键词:
cardiovascular disease;
coronary artery disease;
glucose abnormalities;
high-density lipoprotein cholesterol;
low-density lipoprotein cholesterol;
STATIN-TREATED PATIENTS;
APOLIPOPROTEIN-A-I;
HEART-DISEASE;
CARDIOVASCULAR-DISEASE;
HDL CHOLESTEROL;
INSULIN-RESISTANCE;
TOLERANCE STATUS;
LDL CHOLESTEROL;
MORTALITY;
JAPAN;
D O I:
10.1111/dom.15956
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Aim: To investigate the association between low-density lipoprotein-cholesterol (LDL-C) levels and coronary artery disease (CAD) incidence based on combining high-density lipoprotein-cholesterol (HDL-C) levels and glucose status. Materials and Methods: In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008-2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL-C levels, seven LDL-C levels and glucose status. Results: During the follow-up period (mean: 5.5 years), 8301 (0.99/1000 person-years) events occurred. The risk of CAD increased from lower LDL-C levels accompanied by lower HDL-C levels regardless of the glucose status. Using the most favourable levels of HDL-C and LDL-C (i.e. 60-99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL-C levels <40 mg/dL and LDL-C levels <80 mg/dL were 2.74 (1.47-5.11), 2.52 (1.30-4.91) and 2.85 (1.68-4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL-C and LDL-C with their least favourable levels (i.e. <40 mg/dL and 180-199 mg/dL, respectively) revealed that the risk of new-onset CAD exhibited a 19-, nine- and seven-fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions: To prevent CAD, LDL-C levels should be strictly controlled in patients with low HDL-C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL-C levels based on glucose tolerance and HDL-C values, is required.
引用
收藏
页码:5845 / 5856
页数:12
相关论文